Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion
Open Access
- 16 August 2006
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 63 (1), 36-40
- https://doi.org/10.1111/j.1365-2125.2006.02734.x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Neuroprotective effects of cystamine in aged parkinsonian miceNeurobiology of Aging, 2006
- Understanding intestinal cysteamine bitartrate absorptionThe Journal of Pediatrics, 2006
- CYTE‐I‐HD: Phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's diseaseMovement Disorders, 2005
- Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington diseaseJournal of Neurochemistry, 2005
- Esomeprazole therapy for gastric acid hypersecretion in children with cystinosisPediatric Nephrology, 2005
- The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamineThe Journal of Pediatrics, 2003
- Cystamine Inhibits Caspase ActivityOnline Journal of Public Health Informatics, 2003
- Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosisJournal of Clinical Endocrinology & Metabolism, 1995
- Cysteamine Therapy for Children with Nephropathic CystinosisThe New England Journal of Medicine, 1987
- Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo.JCI Insight, 1976